FSNUY News and Press, Fresenius SE & Co KGaA ADR From 05/04/22

Fresenius SE & Co. KGaA (FSNUF) Q1 2022 Earnings Conference Call May 4, 2022, 7:30 AM ET Company Participants Stephan Sturm – President & Chief Executive Officer Rachel Empey – Chief Financial Officer Markus Georgi – Head of Investor Relations Conference Call Part...

Carla Kriwet will become the next CEO of Fresenius Medical Care (NYSE:FMS) effective Jan. 1, 2023, succeeding Rice Powell, who headed the company for 10 years. Also, Helen Giza, Fresenius' (OTCPK:FSNUF) (OTCPK:FSNUY) CFO, will assume the role of deputy CEO at that time. Kriwet is currently CE...

Fresenius is an interesting investment - certainly in part because it doesn't require an ADR, you can invest in the medical care wing with the symbol FMS. The company's organic growth has been slowed down, and the recovery for the company is likely in the future - but the upside is no...

Fresenius is a diversified healthcare company. The company pays out a growing dividend. A potential break-up and the reduced effect of Covid could act as tailwinds for the company. For further details see: Fresenius: Undervalued Healthcare Giant

The war in Ukraine continues to dominate market movements. I am not selling anything and predominantly focus on adding dividend income via select purchases. The combination of soaring inflation and geopolitical uncertainty has rattled markets but despite some dramatic movements, s...

Fresenius Medical Care's (FMS +0.3%) Fresenius Kabi subsidiary has inked two deals including the acquisition of infusion system provider Ivenix and taking a majority stake in mAbxience, whose pipeline is focused on biosimilars. Terms of the Ivenix acquisition call for Fresenius Kabi (FSNUF +9...

The war in Ukraine has overshadowed any other market development in February. I have kept my portfolio intact and made a couple of purchases while divesting one small position. The combination of soaring inflation and geopolitical uncertainty has rattled markets but despite some d...

This month I had a total of 10 transactions, of which 8 buys and 2 sells. Dividends were up, but February tends to be the lowest amount in dividends received. My new forward dividend yield is $900.04 after-tax. For further details see: My Portfolio February Update - 8 Bu...

Fresenius SE & Co. KGaA (FSNUF) Q4 2021 Earnings Conference Call February 22, 2022, 07:30 AM ET Company Participants Markus Georgi - Head of Investor Relations Stephan Sturm - President & Chief Executive Officer Rachel Empey - Chief Financial Officer Conference Call Participants Veron...

The following slide deck was published by Fresenius SE & Co. KGaA in conjunction with their 2021 Q4 earnings call. For further details see: Fresenius SE & Co. KGaA 2021 Q4 - Results - Earnings Call Presentation